{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:25:51Z","timestamp":1790673951461,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Neonatal seizures are a common neurological emergency in newborns. Phenobarbital (PB) is the first-line antiepileptic drug (AED). However, PB has some side effects, such as hypotension and respiratory depression, and it can accelerate neuronal apoptosis in the immature brain. Levetiracetam (LEV), a new antiepileptic drug, has been used as a second-line drug for the treatment of neonatal seizures. Compared with PB, LEV has many advantages, including a low incidence of side effects and better neurodevelopmental outcomes. However, there are only a few systematic reviews of LEV for the treatment of neonatal seizures.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To evaluate the efficacy and safety of LEV for neonatal seizures and to compare the efficacy, side effects, and neurological outcomes between LEV and PB in the treatment of neonatal seizures.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    The keywords LEV, PB, and neonatal seizure were searched in the MEDLINE, Cochrane Library, Web of Science, EMBASE, clinicaltrials.gov, and China National Knowledge Internet (CNKI) databases with a last update in July 2021 to collect high-quality studies. We collected studies studying the efficacy or safety of LEV and PB in the treatment of neonatal seizures applying strict inclusion and exclusion criteria. The data were extracted and outcome measures, including efficacy, side effect rate, neurological score, and mortality rate, were analyzed with RevMan 5.3 software.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Ten articles were finally included in the meta-analysis. The meta-analysis showed that there was no difference in efficacy between LEV and PB in the treatment of neonatal seizures. Compared with PB, the incidence of side effects of LEV was lower. The incidence of hypotension and respiratory depression in the LEV group was significantly lower than that in the PB group. In terms of long-term neurodevelopmental outcomes, there was no significant difference in the Bayley Scales of Infant Development (BSID) scores between LEV and PB.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    PB is still the first-line AED recommended by the WHO for the treatment of neonatal seizures. The new AEDs LEV may not have better efficacy than PB. At the same time, LEV is associated with better neurodevelopment outcomes and a lower risk of adverse effects. In addition, continuous EEG monitoring should be used to diagnose neonatal seizures to evaluate the severity of the seizures, remission, and drug efficacy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Systematic Review Registration:<\/jats:bold>\n                    PROSPERO, identifier: CRD42021279029.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.747745","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T23:48:00Z","timestamp":1637192880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Meng-Yuan","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Tao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Zhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Kun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Xiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.siny.2013.05.008","article-title":"Epidemiology and aetiology of neonatal seizures","volume":"18","author":"Vasudevan","year":"2013","journal-title":"Semin Fetal Neonatal Med."},{"key":"B2","volume-title":"Guidelines on Neonatal Seizures","year":"2011"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e20193182","DOI":"10.1542\/peds.2019-3182","article-title":"Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial","volume":"145","author":"Sharpe","year":"2020","journal-title":"Pediatrics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3683548","DOI":"10.1155\/2019\/3683548","article-title":"Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus levetiracetam: a single-center experience","volume":"2019","author":"Falsaperla","year":"2019","journal-title":"Behav Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.siny.2017.07.008","article-title":"The use of phenobarbital and other anti-seizure drugs in newborns","volume":"22","author":"El-Dib","year":"2017","journal-title":"Semin Fetal Neonatal Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/0883073810384263","article-title":"Levetiracetam for treatment of neonatal seizures","volume":"26","author":"Abend","year":"2011","journal-title":"J Child Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","article-title":"Use of intravenous levetiracetam for management of acute seizures in neonates","volume":"44","author":"Khan","year":"2011","journal-title":"Pediatr Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/jpet.107.126250","article-title":"Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy","volume":"323","author":"Kim","year":"2007","journal-title":"J Pharmacol Exp Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/jp.2013.116","article-title":"Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures","volume":"33","author":"Maitre","year":"2013","journal-title":"J Perinatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2020.1844651","article-title":"Efficacy of Levetiracetam in neonatal seizures: a systematic review","author":"Sharma","year":"2020","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1528-1167.2007.01285.x","article-title":"Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain","volume":"48","author":"Kim","year":"2007","journal-title":"Epilepsia."},{"key":"B14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/pr.2012.151","article-title":"Antiepileptic effects of levetiracetam in a rodent neonatal seizure model","volume":"73","author":"Talos","year":"2013","journal-title":"Pediatr Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.earlhumdev.2012.12.002","article-title":"The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury","volume":"89","author":"Kilicdag","year":"2013","journal-title":"Early Hum Dev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/jamapediatrics.2017.5211","article-title":"Comparative effectiveness of levetiracetam vs phenobarbital for infantile epilepsy","volume":"172","author":"Grinspan","year":"2018","journal-title":"JAMA Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hern\u00e1ndez-D\u00edaz","year":"2012","journal-title":"Neurology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-0037-1608653","article-title":"A systematic review of the efficacy of levetiracetam in neonatal seizures","volume":"49","author":"McHugh","year":"2018","journal-title":"Neuropediatrics."},{"key":"B19","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"B20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/epi.16469","article-title":"A retrospective comparison of phenobarbital and levetiracetam for the treatment of seizures following cardiac surgery in neonates","volume":"61","author":"Thibault","year":"2020","journal-title":"Epilepsia."},{"key":"B22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5863\/1551-6776-26.2.144","article-title":"Levetiracetam compared to phenobarbital as a first line therapy for neonatal seizures: an unexpected influence of benzodiazepines on seizure response","volume":"26","author":"Wagner","year":"2021","journal-title":"J Pediatr Pharmacol Ther."},{"key":"B23","first-page":"18","article-title":"Clinical comparative analysis of levetiracetam and phenobarbital in treatment of neonatal convulsions","volume":"51","author":"Tan","year":"2019","journal-title":"Digest World Latest Med Inf."},{"key":"B24","unstructured":"The random and comparative study on therapeutic effect and safety between levetiracetam and phenobarbital administration for neonatal seizures9104\n            LiJ\n            YangYX\n            ChenX\n            WangXX\n            JiangL\n          Chin J Appl Clin Pediatr.122016"},{"key":"B25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13312-019-1586-3","article-title":"Levetiracetam versus phenobarbitone in neonatal seizures - a randomized controlled trial","volume":"56","author":"Gowda","year":"2019","journal-title":"Indian Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00381-019-04286-x","article-title":"Neurodevelopmental outcomes at 9-14 months gestational age after treatment of neonatal seizures due to brain injury","volume":"35","author":"Ghosh","year":"2019","journal-title":"Childs Nerv Syst."},{"key":"B27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.seizure.2020.06.006","article-title":"Comparison of the neurocognitive outcomes in term infants treated with levetiracetam and phenobarbital monotherapy for neonatal clinical seizures","volume":"80","author":"Arican","year":"2020","journal-title":"Seizure."},{"key":"B28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.25959","article-title":"A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures","volume":"89","author":"Soul","year":"2021","journal-title":"Ann Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.seizure.2010.01.003","article-title":"Levetiracetam in the treatment of neonatal seizures: a pilot study","volume":"19","author":"F\u00fcrwentsches","year":"2010","journal-title":"Seizure."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","article-title":"Levetiracetam: safety and efficacy in neonatal seizures","volume":"15","author":"Ramantani","year":"2011","journal-title":"Eur J Paediatr Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pediatrneurol.2013.05.008","article-title":"Role of intravenous levetiracetam for acute seizure management in preterm neonates","volume":"49","author":"Khan","year":"2013","journal-title":"Pediatr Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5409\/wjcp.v4.i3.45","article-title":"Response of levetiracetam in neonatal seizures","volume":"4","author":"Yau","year":"2015","journal-title":"World J Clin Pediatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.17712\/nsj.2016.3.20150726","article-title":"Efficacy and safety of levetiracetam in the management of seizures in neonates","volume":"21","author":"Sedighi","year":"2016","journal-title":"Neurosciences."},{"key":"B34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jpn.JPN_172_16","article-title":"Levetiracetam in neonatal seizures as first-line treatment: a prospective study","volume":"12","author":"Falsaperla","year":"2017","journal-title":"J Pediatr Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/0883073816678102","article-title":"Levetiracetam for the treatment of seizures in neonatal hypoxic ischemic encephalopathy","volume":"32","author":"Venkatesan","year":"2017","journal-title":"J Child Neurol."},{"key":"B36","unstructured":"Oral levetiracetam as add-on therapy in refractory neonatal seizures10310\n            MollamohammadiM\n            AmirhoseiniZS\n            SaadatiA\n            PirzadehZ\n            HassanAM\n          30279713Iran J Child Neurol.122018"},{"key":"B37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yebeh.2018.09.015","article-title":"A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy","volume":"88","author":"Rao","year":"2018","journal-title":"Epilepsy Behav."},{"key":"B38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12887-018-1103-1","article-title":"Efficacy of levetiracetam for neonatal seizures in preterm infants","volume":"18","author":"Han","year":"2018","journal-title":"BMC Pediatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1080\/14767058.2018.1481946","article-title":"Efficacy of levetiracetam in premature infants: our experience and review of the literature","volume":"32","author":"\u00d6zalkaya","year":"2019","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5863\/1551-6776-24.4.320","article-title":"Effectiveness of Levetiracetam as a first-line anticonvulsant for neonatal seizures","volume":"24","author":"Kreimer","year":"2019","journal-title":"J Pediatr Pharmacol Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41372-019-0498-3","article-title":"Lack of response to treatment with levetiracetam in extreme preterm infants with seizures","volume":"39","author":"Kurtom","year":"2019","journal-title":"J Perinatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/00207454.2019.1687469","article-title":"Efficacy and safety of levetiracetam in the off-label treatment of neonatal seizures","volume":"130","author":"Liu","year":"2020","journal-title":"Int J Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.seizure.2020.08.030","article-title":"High-dose levetiracetam for neonatal seizures: a retrospective review","volume":"82","author":"Hnaini","year":"2020","journal-title":"Seizure."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-020-01366-7","article-title":"Efficacy of levetiracetam as first-line therapy for neonatal clinical seizures and neurodevelopmental outcome at 12 months of age","author":"Kanmaz","year":"2020","journal-title":"Acta Neurol Belg."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/dmcn.14943","article-title":"Levetiracetam as the first-line treatment for neonatal seizures: a systematic review and meta-analysis","volume":"63","author":"Hooper","year":"2021","journal-title":"Dev Med Child Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.747745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T23:48:05Z","timestamp":1637192885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.747745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":45,"alternative-id":["10.3389\/fneur.2021.747745"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.747745","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"article-number":"747745"}}